From FiSolve, the United States Department of Justice announced five individuals were charged in a 19-count indictment for their participation in a scheme to trade securities based on material nonpublic information about a merger between two pharmaceutical companies that resulted in profits of over $600,000.  The defendants are charged with securities fraud, insider trading and conspiracy.  If convicted, they could face sentences of 25 years in prison.  Read more here.